02:27 AM EDT, 10/29/2026 (MT Newswires) -- Idorsia (IDIA.SW) logged 53 million francs in net loss for the third quarter, compared with a net loss of 86 million francs a year ago. Loss per share moved to 0.20 franc from 0.40 franc year over year, a Thursday filing showed. For the three months ended Sept. 30, net revenue was 62 million francs versus 41 million francs previously, the Swiss-listed biopharmaceutical group added. Analysts polled by FactSet were expecting 53.3 million francs in sales, 52.5 million francs in net loss, and a loss per share of 0.20 franc. Looking ahead, the company affirmed its guidance of an improvement in operating loss in 2026.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.